GB202011128D0 - Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes - Google Patents

Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes

Info

Publication number
GB202011128D0
GB202011128D0 GBGB2011128.2A GB202011128A GB202011128D0 GB 202011128 D0 GB202011128 D0 GB 202011128D0 GB 202011128 A GB202011128 A GB 202011128A GB 202011128 D0 GB202011128 D0 GB 202011128D0
Authority
GB
United Kingdom
Prior art keywords
cannabidiol
treatment
seizures associated
epilepsy syndromes
rare
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2011128.2A
Other versions
GB2597286A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GW Research Ltd
Original Assignee
GW Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GW Research Ltd filed Critical GW Research Ltd
Priority to GB2011128.2A priority Critical patent/GB2597286A/en
Publication of GB202011128D0 publication Critical patent/GB202011128D0/en
Priority to PCT/EP2021/069858 priority patent/WO2022017930A1/en
Publication of GB2597286A publication Critical patent/GB2597286A/en
Pending legal-status Critical Current

Links

GB2011128.2A 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes Pending GB2597286A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB2011128.2A GB2597286A (en) 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes
PCT/EP2021/069858 WO2022017930A1 (en) 2020-07-20 2021-07-15 Use of cannabidiol in the treatment of seizures associated with jeavon's syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2011128.2A GB2597286A (en) 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes

Publications (2)

Publication Number Publication Date
GB202011128D0 true GB202011128D0 (en) 2020-09-02
GB2597286A GB2597286A (en) 2022-01-26

Family

ID=72339084

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2011128.2A Pending GB2597286A (en) 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes

Country Status (2)

Country Link
GB (1) GB2597286A (en)
WO (1) WO2022017930A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2530001B (en) * 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2539472A (en) * 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
GB2568929A (en) * 2017-12-01 2019-06-05 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
GB2569961B (en) * 2018-01-03 2021-12-22 Gw Res Ltd Pharmaceutical

Also Published As

Publication number Publication date
WO2022017930A1 (en) 2022-01-27
GB2597286A (en) 2022-01-26

Similar Documents

Publication Publication Date Title
IL284758A (en) Use of cannabinoids in the treatment of comorbidities associated with epilepsy
GB202019301D0 (en) Use of cannabidiol in the treatment of seizures associated with epilepsy syndromes
GB202011128D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes
GB202011123D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
GB202011175D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011168D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011178D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011166D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011174D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011160D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011161D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011159D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011156D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011169D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011155D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202014250D0 (en) Use of cannabidivarin in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011164D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy sydromes related to genetic abnormalities
GB202011139D0 (en) Use of cannabidiol, in the treatment of seizures associated with rare epilepsy sundromes
GB202011143D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abbormalities of the brain
GB202011150D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
GB202011140D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
GB202011154D0 (en) Use of cannabidiol in the treatment of seizures associated with encephaltis
GB202011163D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epliepsy syndromes related to genetic abnormalites
GB202011126D0 (en) Use of cannabidiol in the treatment of sezures associated with mutifocal epilepsy
GB202011173D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities